Unicycive Therapeutics (UNCY)
(Delayed Data from NSDQ)
$0.46 USD
+0.02 (3.86%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $0.46 0.00 (0.66%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for Unicycive Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -30.54 | -18.06 | -10.02 | -2.26 | -2.17 |
Depreciation/Amortization & Depletion | 0.28 | 0.16 | 0.50 | 0.19 | 0.10 |
Net Change from Assets/Liabilities | -0.09 | 1.18 | -0.10 | -0.17 | 0.31 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 12.07 | 1.07 | 3.85 | 0.79 | 0.59 |
Net Cash From Operating Activities | -18.28 | -15.65 | -5.77 | -1.46 | -1.18 |
Property & Equipment | -0.01 | 0.00 | -0.03 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.01 | 0.00 | -0.03 | 0.00 | 0.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 30.19 | 0.01 | 22.39 | 0.14 | 1.17 |
Issuance (Repayment) of Debt | -0.50 | -0.48 | -0.01 | 1.42 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -2.15 | 0.00 | 0.00 | -0.12 | 0.00 |
Net Cash from Financing Activities | 27.54 | -0.47 | 22.38 | 1.44 | 1.17 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 9.25 | -16.12 | 16.58 | -0.02 | -0.01 |
Cash at Beginning of Period | 0.46 | 16.58 | 0.00 | 0.02 | 0.03 |
Cash at End of Period | 9.70 | 0.46 | 16.58 | 0.00 | 0.02 |
Diluted Net EPS | -1.28 | -1.20 | -0.86 | -0.27 | NA |
Fiscal Year End for Unicycive Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -20.96 | -30.54 | -22.75 | -18.41 |
Depreciation/Amortization & Depletion | NA | 0.28 | 0.28 | 0.20 | 0.12 |
Net Change from Assets/Liabilities | NA | 1.89 | -0.09 | -1.21 | -1.51 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 12.33 | 12.07 | 9.91 | 10.38 |
Net Cash From Operating Activities | NA | -6.46 | -18.28 | -13.84 | -9.42 |
Property & Equipment | NA | -0.01 | -0.01 | -0.01 | -0.01 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -0.01 | -0.01 | -0.01 | -0.01 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 50.00 | 30.19 | 30.19 | 30.19 |
Issuance (Repayment) of Debt | NA | -0.50 | -0.50 | -0.29 | -0.24 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -3.81 | -2.15 | -2.15 | -2.15 |
Net Cash from Financing Activities | NA | 45.69 | 27.54 | 27.75 | 27.80 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 39.23 | 9.25 | 13.89 | 18.36 |
Cash at Beginning of Period | NA | 9.70 | 0.46 | 0.46 | 0.46 |
Cash at End of Period | NA | 48.93 | 9.70 | 14.35 | 18.82 |
Diluted Net EPS | NA | -0.61 | 0.11 | -0.13 | -0.29 |